Although the absolute percentage of ER+ cells of the primary tumor is unknown and may explain this observation, an attractive alternative hypothesis for these originally ER+ samples with low ESR1 expression, is that the tumor cells may have switched from ER-dependent growth to using alternative pathways. This evidence concerns the gene ESR1 and neoplasm.